(Q33694978)

28 July 2017

1 reference

title

Current status of androgen suppression and radiotherapy for patients with prostate cancer (English)

1 reference

adaptive radiation therapy

28 July 2017

main subject

0 references

author name string

Roach M 3rd

series ordinal

1

1 reference

28 July 2017

publication date

1 April 1999

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

28 July 2017

published in

1 reference

28 July 2017

volume

69

1 reference

28 July 2017

issue

1-6

1 reference

28 July 2017

page(s)

239-245

1 reference

Fast neutron radiotherapy for locally advanced prostate cancer: results of an RTOG randomized study

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Population-based study of long-term survival in patients with clinically localised prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Survival after radical retropubic prostatectomy of men with clinically localized high grade carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Radical prostatectomy for high grade disease: a reevaluation 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Can Radical Prostatectomy Alter the Progression of Poorly Differentiated Prostate Cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Neoadjuvant hormonal downsizing of localized carcinoma of the prostate: effects on the volume of normal tissue irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Estramustine potentiates the effects of irradiation on the Dunning (R3327) rat prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Leuprolide with and without flutamide in advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Efficacy of the combination of nilutamide plus orchidectomy in patients with metastatic prostatic cancer. A meta-analysis of seven randomized double-blind trials (1056 patients).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Long-term efficacy and safety of nilutamide plus castration in advanced prostate cancer, and the significance of early prostate specific antigen normalization. International Anandron Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

DHT in prostate cancer tissue--a guide to management and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Relationship between human prostatic epithelial cell protein synthesis and tissue dihydrotestosterone level

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Effects of castration compared with total androgen blockade on tissue dihydrotestosterone (DHT) concentration in benign prostatic hyperplasia (BPH)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Comparison of dihydrotestosterone levels in prostatic cancer metastases and primary prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Basis for hormonal management of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Comparison of androgen-independent growth and androgen-dependent growth in BPH and cancer tissue from the same radical prostatectomies in sponge-gel matrix histoculture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2899%2900040-0

7 January 2021

10.1016/S0960-0760(99)00040-0

Identifiers

DOI

1 reference

28 July 2017

1 reference